Condition: Coagulation Disorder · Sponsor: Takeda
The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagulation reversal in participants treated with Factor Xa inhibitors who require urgent surgery/invasive procedure. The participant will be assigned by chance to either TAK-330 or SOC 4F-PCC as part of standard treatment before surgery. Patients participating in this study will need to be hospitalized. They will also be contacted (via telehealth/phone call) 30 days after the surgery.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| University of Arkansas Medical Sciences | Arkansas City, Arkansas, United States | Recruiting |
| University of California Davis Health System | Sacramento, California, United States | Recruiting |
| Denver Metro Orthopedics, P.C. | Englewood, Colorado, United States | Recruiting |
| University of Florida | Gainesville, Florida, United States | Recruiting |
| Rutgers, The State University of New Jersey | New Brunswick, New Jersey, United States | Recruiting |
| ECU Health Medical Center | Greenville, North Carolina, United States | Recruiting |
| Metro Health Medical Center | Cleveland, Ohio, United States | Recruiting |
| Ohio State University | Columbus, Ohio, United States | Recruiting |
| Ascension St. John Medical Center | Tulsa, Oklahoma, United States | Recruiting |
| University of Pennsylvania - Perelman School of Medicine | Philadelphia, Pennsylvania, United States | Recruiting |
| UPMC | Pittsburgh, Pennsylvania, United States | Recruiting |
| University of Texas Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
+ 52 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05156983